Endo International Plc
(NASDAQ : ENDP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 10.38%48.510.0%$558.21m
VRXValeant Pharmaceuticals International, Inc. -1.02%27.2714.1%$160.46m
CTLTCatalent, Inc. -1.56%136.012.0%$156.22m
PRGOPerrigo Co. Plc -1.11%43.796.9%$137.53m
ICLRICON plc -0.94%268.192.8%$117.70m
INDPIndaptus Therapeutics, Inc. -12.95%10.080.0%$111.65m
HZNPHorizon Therapeutics Plc 1.63%109.715.5%$103.63m
JAZZJazz Pharmaceuticals Plc 1.12%133.222.1%$97.67m
ARGXargenx SE 2.50%331.670.0%$60.05m
ENDPEndo International Plc 4.04%2.838.5%$55.42m
AXSMAxsome Therapeutics, Inc. 4.17%29.721.8%$52.84m
UTHRUnited Therapeutics Corp. -2.47%200.0814.0%$50.73m
BHCBausch Health Cos., Inc. -1.02%27.270.0%$49.51m
SNOASonoma Pharmaceuticals, Inc. 0.75%5.353.4%$33.25m
SAGESAGE Therapeutics, Inc. 2.43%46.407.6%$22.43m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.